Colorblind people might have a unique disadvantage in noticing an early warning sign of certain cancers, a new study suggests.

The S&P 500 fell 2.06% to 6,797, while the Nasdaq Composite lost 2.39% to finish at 22,954. Within biotechnology, peers moved mixed, as Moderna closed at $43.00 (+4.56%) and Novavax ended at $8.20 (+0 ...

Though firefighters brave blazes, rescues and other daily dangers, their leading cause of death is far less obvious: cancer ...

Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its evaluation of this information to potentially support a resubmission of the sBLA ...

Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its ...

Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis.

The class B drug has some very nasty effects on the body ...

Today, Jan. 23, 2026, profit taking and fresh glioblastoma survival data weighed on a soaring biotech stock. ImmunityBio ( ...

A CUTTING-EDGE cold laser therapy could effectively treat prostate cancer and slash the risk of any debilitating side effects. Australian researchers discovered that the new treatment could ...

Cervical cancer symptoms an NYU Langone Health doctor monitors in her own body include irregular vaginal bleeding, abnormal ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Intelligent Scopes Corp secures regulatory green light for its new bladder cancer software. An increasing focus on advanced ...